The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 30, 2019

Filed:

May. 17, 2016
Applicant:

The General Hospital Corporation, Boston, MA (US);

Inventors:

J. Keith Joung, Winchester, MA (US);

Jeffry D. Sander, Ankeny, IA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); C12N 15/10 (2006.01); C12N 15/66 (2006.01); C12P 19/34 (2006.01); C40B 40/08 (2006.01); C40B 50/06 (2006.01); C12P 21/02 (2006.01); C07K 14/195 (2006.01); C12Q 1/6806 (2018.01);
U.S. Cl.
CPC ...
C07K 14/195 (2013.01); C12N 9/22 (2013.01); C12N 15/1093 (2013.01); C12N 15/66 (2013.01); C12P 19/34 (2013.01); C12P 21/02 (2013.01); C12Y 301/00 (2013.01); C40B 40/08 (2013.01); C40B 50/06 (2013.01); C07K 2319/00 (2013.01); C07K 2319/24 (2013.01); C07K 2319/41 (2013.01); C07K 2319/43 (2013.01); C07K 2319/80 (2013.01); C12Q 1/6806 (2013.01);
Abstract

The disclosure describes methods that include providing a first nucleic acid having a sequence encoding a first set comprising one or more transcription activator-like effector (TALE) repeat domains and/or one or more portions of one or more TALE repeat domains; contacting the first nucleic acid with a first enzyme, wherein the first enzyme creates a first ligatable end; providing a second nucleic acid having a sequence encoding a second set comprising one or more TALE repeat domains and/or one or more portions of one or more TALE repeat domains; contacting the second nucleic acid with a second enzyme, wherein the second enzyme creates a second ligatable end, and wherein the first and second ligatable ends are compatible; and ligating the first and second nucleic acids through the first and second ligatable ends to produce a first ligated nucleic acid, wherein the first ligated nucleic acid is linked to a solid support, and wherein the first ligated nucleic acid encodes a polypeptide comprising said first and second sets.


Find Patent Forward Citations

Loading…